Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment
Meiying Song, Jie Liang, Luoyang Wang, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110757-110757
Closed Access | Times Cited: 22

Showing 22 citing articles:

The role of interleukin-17 in inflammation-related cancers
Xingru Zhang, Bin Li, Lü Tian, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
Human Fallopian Tube-Derived Organoids with TP53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous Ovarian Cancer Phenotype In Vitro
Yilin Dai, Jing Xu, Xiaofeng Gong, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 886-886
Open Access | Times Cited: 9
Pathogenic Th17 cell-mediated liver fibrosis contributes to resistance to PD-L1 antibody immunotherapy in hepatocellular carcinoma
Meiying Song, Luoyang Wang, Suli Jiang, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111601-111601
Closed Access | Times Cited: 7
Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?
Marwa Abdel Hamid, Lorenz M. Pammer, Theresa Lentner, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 10, pp. 1258-1270
Open Access | Times Cited: 7
Immune‐related adverse events in non‐small cell lung cancer: Occurrence, mechanisms and therapeutic strategies
Xuwen Lin, Mei Xie, Jie Yao, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 5
Evaluation of the immune-modulatory, anti-oxidant, proliferative, and anti-apoptotic effects of nano-silymarin on mesenchymal stem cells isolated from multiple sclerosis patients' adipose tissue sources
Fahimeh Lavi Arab, Forouzan Yousefi, Mahmoud Reza Jaafari, et al.
Journal of Functional Foods (2024) Vol. 113, pp. 105958-105958
Open Access | Times Cited: 4
Decreased interleukin‐17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice
Jeng‐Kai Jiang, Chi‐Hung Lin, Ting‐An Chang, et al.
Cancer Medicine (2024) Vol. 13, Iss. 5
Open Access | Times Cited: 4
The Pro‐Migratory and Pro‐Invasive Roles of Cancer‐Associated Fibroblasts Secreted IL‐17A in Prostate Cancer
Feng Gao, Xuren Chen, Xinyu Li, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Open Access
Development of a Reliable Cell-Based Reporter Gene Assay for Measuring the Bioactivity of Pharmaceutical Products Targeting Il-17 Signaling Pathway
Weifan Zhu, Yimei Wu, Haiyan Yuan, et al.
(2025)
Closed Access
Chloride intracellular channel 6 inhibits hepatocellular carcinoma progression by modulating immune cell balance and promoting tumor cell apoptosis
He Zhou, Yue Xi, Xueyang Chen
CytoJournal (2025) Vol. 22, pp. 20-20
Open Access
Filgotinib Improves Experimental Pulmonary Fibrosis by Modulating JAK1/STAT3/SOCS3/IL‐17A Signalling
Yunying Lv, Guanghua Zhang, Dexin Kong, et al.
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 4
Closed Access
Modulating tumor immunity using advanced microbiome therapeutics producing an indole metabolite
Troels Holger Vaaben, Ditte Olsen Lützhøft, Andreas Koulouktsis, et al.
EMBO Reports (2025)
Open Access
A synthetic heavy chain variable domain antibody library (VHL) provides highly functional antibodies with favorable developability
Guiying Pang, Ruixue Wang, Hongxu Yang, et al.
Protein Science (2025) Vol. 34, Iss. 4
Closed Access
Combination therapy with immune checkpoint inhibitors in colorectal cancer: Challenges, resistance mechanisms, and the role of microbiota
Ali Rahimi, Zeinab Baghernejadan, Ali Hazrati, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118014-118014
Closed Access
Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non–small cell lung cancer
Jia‐Yi Deng, Ming Gao, Xue Fan, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 6
Open Access
Macrocyclic diterpenoids from Stellera chamaejasme roots alleviate imiquimod‐induced psoriasiform inflammation via STAT1/S100A9 signalling pathway
Yiwen Nie, Xin Liu, Ying Peng, et al.
British Journal of Pharmacology (2025)
Closed Access
IL-17 signaling protects against Helicobacter pylori- induced gastric cancer
Lee C. Brackman, Matthew S. Jung, Emily H. Green, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
IL-17A Drives Oxidative Stress and Cell Growth in A549 Lung Epithelial Cells: Potential Protective Action of Oleuropein
Angela Marina Montalbano, Caterina Di Sano, Giusy Daniela Albano, et al.
Nutrients (2024) Vol. 16, Iss. 13, pp. 2123-2123
Open Access | Times Cited: 1
Combining Metagenomics, Network Pharmacology and RNA-Seq Strategies to Reveal the Therapeutic Effects and Mechanisms of Qingchang Wenzhong Decoction on Inflammatory Bowel Disease in Mice
Yali Yuan, Hairong Hu, Zhongmei Sun, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4273-4289
Open Access | Times Cited: 1
IL-17A in gastric carcinogenesis: good or bad?
Weidong Li, Xiaodong Huang, Xiaowen Han, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Inhibition of the Binding of Interleukin 17A with Interleukin 17A Receptor as a Treatment for Immune System and Inflammation Disorders, Cancer, and Neurodegenerative Diseases
Ahmed F. Abdel‐Magid
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 12, pp. 2088-2090
Open Access
Risk of Malignancy Related to Ixekizumab in Patients in Patients With Psoriatic Arthritis or Axial Spondyloarthropathy
José Ramón Maneiro, Júlia Carmona, Antonio Mera, et al.
JCR Journal of Clinical Rheumatology (2024)
Closed Access
The correlation of bisphenol A exposure on inflammatory cytokines in preschool children
Wei Cai, Qinghong Yan, Yuhong Deng, et al.
Cytokine (2024) Vol. 186, pp. 156835-156835
Closed Access
Page 1

Scroll to top